In this report, we investigated the pathogenic mechanism underlying the deafness-associated mitochondrial(mt) tRNA Asp 7551A > G mutation. The m.7551A > G mutation is localized at a highly conserved nucleotide(A37), adjacent (3 ) to the anticodon, which is important for the fidelity of codon recognition and stabilization in functional tRNAs. It was anticipated that the m.7551A > G mutation altered the structure and function of mt-tRNA Asp 
INTRODUCTION
The defects in mitochondrial protein synthesis have been associated with both syndromic deafness (hearing loss with other medical problems such as diabetes) and nonsyndromic deafness (hearing loss is the only obvious medical problem) (1) (2) (3) (4) (5) . The mitochondrial translation machinery composed of 2 rRNAs and 22 tRNAs, encoded by mitochondrial DNA (mtDNA), and more than 150 proteins (ribosomal proteins, ribosomal assembly proteins, aminoacyl-tRNA synthetases, tRNA-modifying enzymes, and several initiation, elongation and termination factors), encoded by nuclear genes (6) (7) (8) . Mutations in the LARS2 and NARS2 encoding mitochondrial leucyl-tRNA synthetase and asparaginyl-tRNA synthetase have been associated with deafness, respectively (9-10). The mtDNA mutations have been shown to be the important causes of both syndromic and nonsydromic deafness (3) (4) (5) . Of these, the m.1555A > G and m.1494C > T mutations in the 12S rRNA gene have been associated with both aminoglycoside-induced and nonsyndromic deafness in many families worldwide (3, 4, 11, 12) . The most prevalent mtDNA mutations associated with syndromic deafness are the MELAS-associated m.3243A > G mutation in the mt-10003T > C and mt-tRNA Ile 4295A > G mutations (15) (16) (17) (18) (19) (20) (21) . These mt-tRNA mutations altered their structures and functions, including the processing of the mt-tRNA from the primary transcripts, stability of the folded secondary structure, the charging of the mt-tRNA, or the codonanticodon interaction in the process of translation (5, 22, 23) . The m.7445A > G mutation altered the processing of the 3 end mt-tRNA Ser(UCN) precursor (24) , the m.7511T > C mutations affected the stability of mt-tRNA Ser(UCN) (25) and m.12201T > C mutation altered the aminoacylation of mt-tRNA His (20) . However, the pathophysiology of these tRNA mutations remains poorly understood.
As the part of a genetic screening program for deafness in a cohort of 2651 Han Chinese affected subjects, we identified the novel m.7551A > G mutation in the mt-tRNA Asp gene in one Han Chinese pedigrees with maternal transmission of nonsyndromic deafness (19, 26) . As shown in Figure 1 , the m.7551A > G mutation is localized at a highly conserved nucleotide (A37), adjacent (3 ) to the anticodon of mt-tRNA Asp (22, 23) . There were no modifications of i 6 A37 or t 6 A37 in the human mitochondrial tRNA Asp (27) , although the nucleotides at position 37 (A or G) of tRNAs are often modified by methylthiolation (28) (29) . The modifications at position 37 were shown to contribute to the high fidelity of codon recognition and to the structural formation and stabilization of functional tRNAs (30) (31) (32) (33) . Thus, the substitution of A with G at position 37 of the mt-tRNA Asp may introduce the m 1 G37 modification of this tRNA, thereby altering the structure and function of mt-tRNA Asp . In particular, the mutation may affect the aminoacylation capacity and stability of this mt-tRNA and then impair mitochondrial translation. It was also proposed that an impairment of mitochondrial translation caused by the mt-tRNA mutation alters the respiration, production of adenosine triphoshate (ATP) and reactive oxygen species (ROS). To further investigate the pathogenic mechanism of the m.7551A > G mutation, cybrid cell lines were constructed by transferring mitochondria from lymphoblastoid cell lines derived from an affected matrilineal relative in a Chinese family carrying the mtDNA mutation and from a control individual lacking the mtDNA mutation, into human mtDNA-less (
• ) cells (34) (35) . First, we examined if the m.7551A > G mutation created the m 1 G37 modification of mt-tRNA Asp by using primer extension. These resultant cybrid cell lines were then assessed for the effects of the mtDNA mutation on the aminoacylation capacity and stability of this mt-tRNA, mitochondrial translation, respiration and the production of ATP and ROS as well as mitochondrial membrane potential.
MATERIALS AND METHODS

Cell lines and culture conditions
Immortalized lymphoblastoid cell lines were generated from one affected matrilineal relative (III-6) of the Chinese family carrying the m.7551A > G mutation (26) and one genetically unrelated Chinese control individual (A4) belonging to the same mtDNA haplogroup but lacking the mutation (Supplementary Table S1 ) (36) . These cell lines were grown in RPMI 1640 medium with 10% fetal bovine serum. The bromodeoxyuridine (BrdU) resistant 143B.TK − cell line was grown in Dulbecco's Modified Eagle Medium (Life Technologies) (containing 4.5 mg of glucose and 0.11 mg pyruvate/ml), supplemented with 100 g of BrdU/ml and 5% fetal bovine serum. The mtDNA-less
• 206 cell line, derived from 143B.TK − (34, 35) was grown under the same conditions as the parental line, except for the addition of 50 g of uridine/ml. Transformation by cytoplasts of mtDNAless
• 206 cells using one affected subject (III-6) and one control individual (A4) was performed as described elsewhere (34, 35, 37) . All cybrid cell lines constructed with enucleated lymphoblastoid cell lines were maintained in the same medium as the 143B.TK − cell line. An analysis for the presence and level of the m.7551A > G mutation was carried out as described previously (26) . The quantification of mtDNA copy number from different cybrids was performed as detailed elsewhere (38) .
Detection of m
1 G37 modification in mt-tRNA Asp using primer extension
To determine the nucleotide positions of m 1 G modification of mt-tRNA Asp , a primer extension experiment was performed by a modified procedure, as detailed elsewhere (39, 40) . Mitochondria were isolated from three mutant and three control cybrids (∼2.0 × 10 8 cells), as described previously (41) . Total mitochondrial RNAs were isolated using TOTALLY RNA TM kit (Ambion), as described previously. A DNA primer (5 -TGGUAAGATATATAGGATTTAGCCTATAAT-3 ) complementary to the 3 end of the mt-tRNA Asp was 5 end labeled with non-radioactive digoxin (DIG). Primescript II 1st Strand cDNA Synthesis Kit (TAKARA) was used for reverse transcription with DIG-labeled oligodeoxynucleotide probe specific for the mt-tRNA Asp by using total mt-RNA as templates. Extension reactions were carried out as detailed previously (39, 40) . Finally, samples were applied onto 15% polyacrylamide-7 M urea gel electrophoresis and electroblotted onto a positively charged nylon membrane. Quantification of density in each band was performed as detailed previously (40) .
Mitochondrial tRNA Northern analysis
Two micrograms of total mitochondrial RNA were electrophoresed through a 10% polyacrylamide/7 M urea gel in Tris-borate-EDTA buffer (after heating the sample at 65
• C for 10 min). The gels were then electroblotted onto a positively charged nylon membrane (Roche) for the hybridization analysis with DIG-labeled oligodeoxynucleotide probes for mt-tRNA Asp , mt-tRNA Thr , mt-tRNA Leu(CUN) , mt-tRNA Lys and mt-tRNA Ser(AGY) were as detailed previously (20, 24, 25, 42, 43) . DIG-labeled oligodeoxynucleotides were generated by using DIG oligonucleotide Tailing kit (Roche). The hybridization and quantification of density in each band were performed as detailed previously (20, 24, 25) . For the aminoacylation assays, total mitochondrial RNAs were isolated under acid conditions, and 2 g of total mitochondrial RNAs was electrophoresed at 4
• C through an acid (pH 3.0) 10% polyacrylamide-7 M urea gel to separate the charged and uncharged tRNA as detailed elsewhere (43, 44) . To further distinguish non-aminoacylated tRNA from aminoacylated tRNA, samples of tRNAs were deacylated by being heated for 10 min at 60
• C at pH 8.3 and then run in parallel (35, 44) . The gels were then electroblotted onto a positively charged nylon membrane (Roche) for the hybridization analysis with oligodeoxynucleotide probes as described above. Quantification of density in each band was performed as detailed previously (20) .
Western blot analysis
Western blotting analysis was performed as detailed previously (20, 43) . The antibodies used for this investigation were from Abcam [anti GAPDH (ab72655), p.MT-ND1 (ab74257), p.MT-ND5 (ab92624) and p.MT-ATP6 (ab101908), p.MT-CO2 (ab110258)], Santa Cruz Biotechnology [p.MT-ND4 (sc-20499-R) and p.MT-ND6 (sc-20667)] and Proteintech [p.MT-CYTB (55090-1-AP)]. Peroxidase Affini Pure goat anti-mouse IgG and goat antirabbit IgG (Jackson) were used as a secondary antibody and protein signals were detected using the ECL system (CW-BIO). Quantification of density in each band was performed as detailed previously (20, 43) .
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Assays of activities of respiratory complexes
The enzymatic activities of complex I, II, III and IV were assayed as detailed elsewhere (43, 45, 46) .
Measurements of oxygen consumption
The rates of oxygen consumption (OCR) in cybrid cell lines were measured with a Seahorse Bioscience XF-96 extracellular flux analyzer (Seahorse Bioscience), as detailed previously (20, 43, 47) .
ATP measurements
The Cell Titer-Glo ® Luminescent Cell Viability Assay kit (Promega) was used for the measurement of cellular and mitochondrial ATP levels, according to the modified manufacturer's instructions (20, 43) .
Assessment of mitochondrial membrane potential
Mitochondrial membrane potential was assessed with JC-10 Assay Kit-Microplate (Abcam) following general manufacturer's recommendations with some modifications, as detailed elsewhere (20, 35) .
Measurement of ROS production
ROS measurements were performed following the procedures detailed previously (20, 43, 48, 49) .
Computer analysis
Statistical analysis was carried out using the unpaired, twotailed Student's t-test contained in the Microsoft-Excel program or Macintosh (version 2007). Differences were considered significant at a P < 0.05.
RESULTS
The description of one hearing-impaired Chinese pedigree and derived cell lines
The pedigree of the Chinese family with maternally inherited deafness was previously described (19, 26) . Six of 12 matrilineal relatives suffered from the variable degree of hearing impairment (two with mild hearing loss, two with moderate hearing loss and two with profound hearing loss). The age-at-onset of hearing loss ranged from 5 to 45 years, with the average of 26 years. These matrilineal relatives exhibited no other clinical abnormalities, including cardiac failure, muscular diseases, visual failure and neurological disorders. Immortalized lymphoblastoid cell lines were derived from one affected matrilineal relative carrying the m.7551A > G mutation, with profound hearing loss (III-6; male, 21 years) and from one genetically unrelated hearing normal individual lacking the m.7551A > G mutation belong to the same mtDNA haplogroup (A4, male, 20 years). The lymphoblastoid cells were enucleated, and subsequently fused to a large excess of mtDNA-less human
• 206 cells, derived from the 143B.TK-cell line (34, 35) . These cybrid clones were isolated by growing the fusion mixtures in the selective Dulbecco's Modified Eagle Medium, containing BrdU and lacking uridine. Between 25 and 45 days after fusion, 10-15 presumptive mitochondrial cybrids derived from each donor cell line were isolated, and subsequently analyzed for the presence and level of the m.7551A > G mutation (26) . The results confirmed the absence of the mtDNA mutation in the control clones and its presence in homoplasmy in all cybrids derived from the mutant cell line (Supplementary Figure S1) . Three cybrids derived from each donor cell line with similar mtDNA copy numbers were used for the biochemical characterization described below.
The m.7551A > G mutation created the m 1 G37 modification of mt-tRNA Asp There were no modifications of i 6 A37 or t 6 A37 detected in the human mitochondrial tRNA Asp (27) . To investigate if the m.7551A>G mutation produced the m 1 G37 modification of mt-tRNA Asp , we subjected mitochondrial RNAs from mutant and control cybrid cell lines to the reverse transcription with DIG-labeled oligonucleotide probe specific for mt-tRNA Asp ( Figure 1A ). This results in a stop band one residue 3 to the methylation on 15% polyacrylamide gel. As shown in Figure 1B , the m 1 G37 modification was present in mt-tRNA Asp derived from three mutant cell lines, while the m 1 G37 modification was not detected in the mttRNA Asp derived from three control cell lines. Furthermore, the m 1 A9 modifications were detected in mt-tRNA Asp obtained from both control and mutant cell lines.
Reduction in the steady-state level of mt-tRNA Asp
To examine if the m.7551A > G mutation affects the stability of mt-tRNA Asp , we subjected mitochondrial RNAs from cybrids cell lines to Northern blots and hybridized them with DIG-labeled oligodeoxynucleotide probes for mt-tRNA Asp , mt-tRNA Thr , mt-tRNA Leu(CUN) , mt-tRNA Lys and mt-tRNA Ser(AGY) , respectively. As shown in Figure 2A , the amount of mt-tRNA Asp in three mutant cell lines were markedly decreased, compared with those in three control cybrid cell lines. For comparison, the average level of each mt-tRNA Asp in control or mutant cell lines was normalized to the average levels in the same cell line for reference mt-tRNA Thr , mt-tRNA Leu(CUN) , mt-tRNA Lys and mt-tRNA Ser(AGY) , respectively. As shown in Figure 2B , the average steady-state level of mt-tRNA Asp was significantly decreased in the mutant cells, compared with the wild-type cells. In particular, the average levels of mt-tRNA Asp in the mutant cybrid cell lines were among ∼58%, 52%, 64% and 57% of average values of three control cybrids after normalization to mt-tRNA Thr , mt-tRNA Leu(CUN) , mt-tRNA Lys and mt-tRNA Ser(AGY) (P < 0.0018 to 0.0005), respectively.
Deficient aminoacylation of mt-tRNA Asp
We evaluated whether the m.7551A > G mutation alters the aminoacylation of mitochondrial tRNAs. For this purpose, the aminoacylation capacities of mt-tRNA Asp , mt-tRNA Thr , mt-tRNA Leu(CUN) , mt-tRNA Lys and mttRNA Ser(AGY) in control and mutant cell lines were examined by the use of electrophoresis in an acidic polyacrylamide/urea gel system to separate uncharged tRNA species from the corresponding charged tRNA, electroblotting and hybridizing with the tRNA probes described above. As shown in Figure 3A , the upper band represents the charged tRNA, and the lower band represents uncharged tRNA. There were no obvious differences in electrophoretic mobility between the control and mutant cell lines. To further distinguish nonaminoacylated tRNA from aminoacylated tRNA, samples of tRNAs were deacylated by being heated for 10 min at 60
• C at pH 8.3 and then run in parallel. As shown in Figure 3B , only one band (uncharged tRNA) was present in both mutant and control cell lines after deacylating. However, the efficiencies of aminoacylated mt-tRNA Asp in these mutant cell lines carrying the m.7551A > G mutation varied from 74 to 84%, with average of 80%, relative to the average values of control cell lines (P = 0.0072) ( Figure 3C ). However, the levels of aminoacylation in mt-tRNA Thr , mt-tRNA Leu(CUN) , mt-tRNA Lys and mt-tRNA Ser(AGY) in the mutant cell lines were comparable with those in the control cell lines (Supplementary Figure  S2) .
Decreases in the level of mitochondrial proteins
To assess whether a failure in mt-tRNA Asp metabolism caused by the m.7551A > G mutation impaired mitochondrial translation, a Western blot analysis was carried out to examine the steady state levels of seven subunits of respiratory complex in mutant and control cells with GAPDH as a loading control. As shown in Figure 4A , the levels of p.MT-CO1 and p.MT-CO2, subunits I and II of cytochrome c oxidase; p.MT-ND1, p.MT-ND4 and p.MT-ND5, subunits 1, 4 and 5 of NADH dehydrogenase; p.MT-ATP6, subunit 6 of the H±ATPase; p.MT-CYTB, apocytochrome b exhibited the variable reductions in three mutant cell lines, as compared with those of three control cell lines. As shown in Figure 4B , the overall levels of seven mitochondrial translation products in the mutant cell lines ranged from ∼58-76%, with an average of 65% (P = 0.0106), relative to the mean value measured in the control cell lines. Notably, the average levels of p.MT-ND1, p.MT-ND4, p.MT-ND5, p.MT-ND6, p.MT-CO2, p.MT-ATP6 and p.MT-CYTB in the mutant cells were 39%, 64%, 76%, 39%, 70%, 45% and 58% of the average values of control cells, respectively. However, the levels of polypeptide synthesis in mutant cells, relative to those in control cells, showed no significant correlation with either the number of codons or the proportion of aspartic acid residues (Supplementary Table S2 ).
Respiration defects in mutant cells
To evaluate if the m.7551A > G mutation alters cellular bioenergetics, we examined the OCR of three mutant cell lines carrying the m.7551A > G mutation and three control cell lines. As shown in Figure 5 , the basal OCR in the mutant cell lines was ∼59% (P = 0.047) relative to the mean value measured in the control cell lines. To investigate which of the enzyme complexes of the respiratory chain was affected in the mutant cell lines, OCR was measured after the sequential addition of oligomycin (to inhibit the ATP synthase), carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (to uncouple the mitochondrial inner membrane and allow for maximum electron flux through the ETC), rotenone (to inhibit complex I) and antimycin A (to inhibit complex III). The difference between the basal OCR and the drug-insensitive OCR yields the amount of ATP-linked OCR, proton leak OCR, maximal OCR, reserve capacity and non-mitochondrial OCR. As shown in Figure 5 , the ATP-linked OCR, proton leak OCR, maximal OCR, reserve capacity and non-mitochondrial OCR in mutant cell lines were ∼74%, 38%, 61%, 117% and 137%, relative to the mean value measured in the control cell lines (P = 0.065, 0.045, 0.011, 0.330 and 0.084), respectively.
Reduced activities of respiratory chain complexes
To investigate the effect of the m.7551A > G mutation on the oxidative phosphorylation, we measured the activities of respiratory chain complexes by isolating mitochondria from mutant and control cell lines. Complex I (NADH ubiquinone oxidoreductase) activity was determined by following the oxidation of NADH with ubiquinone as the electron acceptor (47, 48) . Complex III (ubiquinone cytochrome c oxidoreductase) activity was measured as the reduction of cytochrome c (III) using d-ubiquinol-2 as the electron donor. The activity of complex IV (cytochrome c oxidase) was monitored by following the oxidation of cytochrome c (II). As shown in Figure 6 , the activity of complexes I, II, III and IV in the mutant cells carrying m.7551A > G mutation were 49%, 104%, 71% and 69% of the mean value measured in three control cell lines, respectively.
Reduced levels in mitochondrial ATP production
The capacity of oxidative phosphorylation in mutant and wild-type cell lines was examined by measuring the levels of cellular and mitochondrial ATP using a luciferin/luciferase assay. Populations of cells were incubated in the media in the presence of glucose, and 2-deoxy-D-glucose with pyruvate (20, 50) . As shown in Figure 7A , the levels of ATP production in mutant cells in the presence of glucose (total cellular levels of ATP) were 80% of those measured in the control cell lines. By contrast, as shown in Figure 7B , the levels of ATP production in mutant cell lines, in the presence of pyruvate and 2-deoxy-D-glucose to inhibit glycolysis (mitochondrial levels of ATP) ranged from 54 to 63%, with an average of 57% relative to the mean value measured in the control cell lines (P = 0.0012). 
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Mild decreases in mitochondrial membrane potentials
The mitochondrial membrane potential ( m) changes were measured in mutant and control cell lines using the fluorescence probe JC-10 assay system. The ratios of fluorescence intensities Ex/Em = 490/590 and 490/530 nm (FL590/FL530) were recorded to delineate the m level of each sample. The relative ratios of FL590/FL530 geometric mean between mutant and control cell lines were calculated to represent the level of m. As shown in Figure 8 , the levels of the Ψ m in the mutant cell lines carrying the m.7551A > G mutation ranged from 77.2% and 96.8%, with an average 86.2% (P = 0.182) of the mean value measured in the control cell lines. In contrast, the levels of Ψ m in mutant cells in the presence of carbonyl cyanide-p-(trifluoromethoxy)phenylhydrazone were comparable with those measured in the control cell lines (P = 0.766).
The increase of ROS production
The levels of the ROS generation in the vital cells derived from three mutant cybrid cell lines carrying the m.7551A > G mutation and three control cybrid cell lines lacking the mutation were measured with flow cytometry under normal conditions and following H 2 O 2 stimulation (20, 49) . Geometric mean intensity was recorded to measure the rate of ROS of each sample. The ratio of geometric mean intensity between unstimulated and stimulated with H 2 O 2 in each cell line was calculated to delineate the reaction upon increasing level of ROS under oxidative stress. As shown in Figure 9 , the levels of ROS generation in the mutant cell lines carrying the m.7551A > G mutation ranged from 126 and 140%, with an average 132% (P = 0.0035) of the mean value measured in the control cell lines.
DISCUSSION
In the present study, we investigated the pathogenetic mechanism of the deafness-associated m.7551A > G mutation in the mt-tRNA Asp gene. The mutation is localized at a highly conserved nucleotide (A37), adjacent to the 3 end of the anticodon of the mt-tRNA Asp (22, 23) . The nucleotide at position 37 of the tRNAs are often modified by methylthiolation (28, 29) . Modification at position A37 of some mitochondrial tRNAs such as mt-tRNA Lys and mt-tRNA Ser(UCN) was catalyzed by the modifying enzymes TRIT1 (MiaA in bacterial ortholog), while the modification of G37 in other tRNAs such as mt-tRNA Leu(CUN) and mttRNA Gln was catalyzed by the TRMT5 (TrmD in bacterial ortholog) (28) (29) (30) . Modification at position 37 contributes to the high fidelity of codon recognition and to the structural formation and stabilization of functional tRNAs (28) (29) (30) (31) . However, the modification of A37 was not detected in human mt-tRNA Asp , mt-tRNA Met and mt-tRNA Leu(UUR) (27, 28) . Thus, it was anticipated that the m.7551A > G mutation created the m 1 G37 modification, thereby altering the structure and function of mt-tRNA Asp . In this study, the primer extension experiment demonstrated that the m.7551A > G mutation produced the m 1 G37 modification of mt-tRNA Asp . The primary defect in this mutation appeared to affect the stability and aminoacylation of mutant mt-tRNA Asp (50, 51) . Unlike the m.12201T > C mutation in the mt-tRNA His and m.15927A > G mutation in the mt-tRNA Thr (20, 50) , the m.7551A > G muta- Asp but no other tRNAs were mildly decreased in mutant cell lines, as compared with controls. In fact, the A-to-G substitution at position 37 resulted in a 10-fold reduction in the amount of bacterial tRNA at the aminoacyl-tRNA binding site (52) . A failure to aminoacylate tRNA properly then makes the mutant mt-tRNA Asp to be metabolically less stable and more subject to degradation, thereby lowering the level of this tRNA, as in the case of m.3243A > G mutation in the mttRNA Leu(UUR) (42, 53) . Alternatively, the m.7551A > G mutation likely affects the formation of functional structure of tRNAs and thus makes the tRNA be more unstable (22, 23) . In the present study, 42% reduction in the steady-state level of mt-tRNA Asp observed in mutant cybrids was consistent with the previous observations in the lymphoblastoid cell lines carrying the m.4435A > G mutation in the tRNA Met gene (32, 33 ). However, the reduced level of mt-tRNA Asp in mutant cells harboring the m.7551A > G mutation is indeed above the proposed threshold to produce a clinical phenotype associated with a mitochondrial tRNA mutation (20, 53, 54) . This suggest that the m.7551A > G mutation alone is not sufficient to produce a clinical phenotype, as in the case of the deafness-associated m.1555A > G and m.1494C > T mutations in the 12S rRNA gene (37, 55) .
A failure in tRNA metabolism including inefficient aminoacylation or shortage of mt-tRNA Asp could be the source of impaired mitochondrial translation of mtDNA encoding polypeptides and subsequent respiratory chain defects. In the present study, reduced levels of mitochondrial proteins (an average decrease of ∼35%) were observed in mutant cybrid cell lines, as compared to the average levels in control cell lines. The reduced levels of variable mitochondrial protein detected in cybrids carrying the m.7551A > G mutation were comparable with the reduced rates of mitochondrial protein synthesis observed in lymphoblastoid cell lines carrying the m.4435A > G mutation (32, 33) . In mutant cell lines, a variable decrease in level of 7 mtDNA-encoded polypeptides was observed in each protein. However, polypeptide levels in mutant cell lines, relative to those in control cell lines, did not significantly correlate with either the number or proportion of aspartic acid codons, in contrast to what was previously shown in cell lines carrying the m.7445A > G mutation in the precursor of mt-tRNA Ser(UCN) (24) or the m.8344A > G mutation in mt-tRNA Lys (54) . The lower level of mt-tRNA Asp may contribute to the variable decrease of each polypeptide in mutant cell lines. Thus, the impaired synthesis of these mtDNA-encoding polypeptides may affect the activities of complex I, complex III and complex IV, respectively. Furthermore, impairment of mitochondrial protein synthesis were apparently responsible for the reduced rates in the basal OCR, or ATP-linked OCR, reserve capacity and maximal OCR among the control and mutant cell lines. These observations were clearly consistent with the critical role of mt-tRNA Asp metabolic failure in producing their respiration defects, as in the cases of mutant cell lines carrying the deafness-associated mt-tRNA Ser(UCN) 7445A > G, 7511T > C and mt-tRNA His 12201T > C mutations (20, 24, 25) .
The respiratory deficiency then affects the efficiency of mitochondrial ATP synthesis. In this investigation, 43% drop in mitochondrial ATP production in mutant cybrids carrying the m.7551A > G mutation may be caused by the defective activities of complexes I, III and IV. The reducing level was comparable with those in cells carrying the deafness-associated m.12201T > C and LHON-associated m.11778G > A mutations (20, 43) , but the decreasing level was much lower than those in cells carrying the mt-tRNA Lys 8344A > G and mt-tRNA Leu(UUR) 3243A > G mutations (56, 57) . Alternatively, the reduction in mitochondrial ATP production in mutant cells was likely a consequence of the decrease in the proton electrochemical potential gradient of mutant mitochondria (56) . As a result, the hair cells carrying the mtDNA mutation may be particularly sensitive to increased ATP demand (3, 4, 58) . Furthermore, the deficient activities of respiratory chain complexes caused by tRNA mutations often alter mitochondrial membrane potentials (59) . In this study, only relatively mild reductions in mitochondrial membrane potential were observed in mutant cell lines carrying the m.7551A > G mutation, in contrast with those in the cell lines carrying the m.12201T > C mutation (20) . The impairment of oxidative phoshorylation can lead to more electron leakage from electron transport chain, and in turn, elevate the production of ROS in mutant cells (60) , thereby damaging mitochondrial and cellular proteins, lipids and nuclear acids (61) . The hair cells and cochlear neurons may be preferentially involved because they are somehow exquisitely sensitive to subtle imbalance in cellular redox state or increased level of free radicals (61) (62) (63) . However, the incomplete penetrance of deafness and mild biochemical defects indicated that the m.7551A > G mutation may be necessary evident but not sufficient to produce a clinical phenotype. The other genetic or epigenetic factors may contribute to the development of clinical phenotype in subjects carrying the m.7551A > G mutation (64, 65) . In particular, the hearing specific phenotype of this tRNA mutation may be attributed to the tissue-specificity of OX-PHOS via tRNA modification or involvement of nuclear modifier genes (64, (66) (67) (68) .
In summary, our findings convincingly demonstrate the pathogenic mechanism leading to an impaired oxidative phosphorylation in cybrid cell lines carrying the deafnessassociated m.7551A > G mutation in the mt-tRNA Asp gene. The m.7551A > G mutation created the m 1 G37 modification of mt-tRNA Asp , but reduced the efficiency of aminoacylation and stability of this tRNA. A failure in tRNA Asp metabolism led to the decreased synthesis of mtDNA encoding polypeptides and respiration. As a result, this respiratory deficiency reduced mitochondrial ATP production and increased the production of oxidative reactive species. The subsequent hearing loss may be involved in the participation of other genetic, epigenetic and environmental modifier factors. Thus, our findings may provide the new insights into the understanding of pathophysiology of maternally inherited deafness that was manifested by altered nucleotide modification of mitochondrial tRNA.
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